Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Neurology|March 1, 1993
Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophyJ T Kissel, D J Lynn, K W Rammohan, et al.
Neurology|December 1, 1991
Long-term benefit from prednisone therapy in Duchenne muscular dystrophyG M Fenichel, J M Florence, A Pestronk, et al.
Neurology|March 1, 1993
Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)R C Griggs, R T Moxley, J R Mendell, et al.
Muscle & Nerve|December 1, 1990
Randomized, double-blind trial of mazindol in Duchenne dystrophyR C Griggs, R T Moxley, J R Mendell, et al.
Archives of Neurology|August 1, 1987
Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisoneM H Brooke, G M Fenichel, R C Griggs, et al.
Archives of Neurology|August 1, 1987
Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controlsJ R Mendell, M A Province, R T Moxley, et al.
European Journal of Neurology|June 5, 2014
Expression and cellular localization of the classical progesterone receptor in healthy and amyotrophic lateral sclerosis affected spinal cordG M Gargiulo-Monachelli, D Campos-Melo, C A Droppelmann, et al.
Muscle & Nerve|November 1, 1988
Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin EG M Fenichel, M H Brooke, R C Griggs, et al.
Neurology|October 14, 2009
Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyR G Miller, C E Jackson, E J Kasarskis, et al.
Neurology|October 14, 2009
Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyR G Miller, C E Jackson, E J Kasarskis, et al.
Pageof 11